Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse

Annals of Family Medicine

Volumn 10, Issue 4, 2012, Pages 304-311

  Grattan, Alicia ^a   Sullivan, Mark D ^a   Saunders, Kathleen W ^b   Campbell, Cynthia I ^c   von Korff, Michael R ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADDICTION; ADOLESCENT; ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; CONFIDENCE INTERVAL; DEPRESSION; FEMALE; HEALTH CARE SURVEY; HUMAN; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; RISK; RISK FACTOR; SELF REPORT; STATISTICS; TIME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; CALIFORNIA; CHRONIC DISEASE; CONFIDENCE INTERVALS; DEPRESSION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; ODDS RATIO; PSYCHOMETRICS; QUESTIONNAIRES; RISK FACTORS; SELF REPORT; STATISTICS AS TOPIC; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 84863945886     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.1371     Document Type: Article

References (41)

1. Centers for Disease Control and Prevention (CDC). Increase in poisoning deaths caused by non-illicit drugs-Utah, 1991-2003. MMWR Morb Mortal Wkly Rep. 2005;54(2):33-36.
2. Ballesteros M F, Budnitz DS, Sanford C P, Gilchrist J, Agyekum GA, Butts J. Increase in deaths due to methadone in North Carolina. JAMA. 2003;290(1):40.
3. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study. Pain. 2010;150(2):332-339.
4. Denisco RA, Chandler RK, Compton WM. Addressing the intersecting problems of opioid misuse and chronic pain treatment. Exp Clin Psychopharmacol. 2008;16(5):417-428.
5. National Institute on Drug Abuse. Pain and Opiophobia. Research Report Series-Prescription Drugs: Abuse and Addiction. http://www.drugabuse.gov/publications/research-reports/prescription-drugs.
6. Smith RC, Frank C, Gardiner JC, Lamerato L, Rost KM. Pilot study of a preliminary criterion standard for prescription opioid misuse. Am J Addict. 2010;19(6):523-528.
7. Morasco BJ, Dobscha SK. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry. 2008;30(2):93-99.
8. Braker LS, Reese AE, Card RO, Van Howe RS. Screening for potential prescription opioid misuse in a Michigan Medicaid population. Fam Med. 2009;41(10):729-734.
9. Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130(1-2): 144-156.
10. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7-23.
11. Von Korff M, Simon G. The relationship between pain and depression. Br J Psychiatry Suppl.1996;(30):101-108.
12. Gureje O, Simon GE, Von Korff M. A cross-national study of the course of persistent pain in primary care. Pain. 2001;92(1-2):195-200.
13. Cowan DT, Wilson-Barnett J, Griffths P, Allan LG. A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med. 2003;4(4):340-351.
14. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inf ammatory drug management of chronic low back pain. J Pain. 2003;4(6):344-350.
15. Sullivan MD, Edlund MJ, Zhang L, Unützer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med. 2006;166(19):2087-2093.
16. Sullivan MD, Edlund MJ, Steffck D, Unützer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119(1-3):95-103.
17. Turk DC, Okifuji A. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain. 1997;13(4):330-336.
18. Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opi-oid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31(6):564-570.
19. Edlund MJ, Martin BC, Devries A, Fan MY, Braden JB, Sullivan MD. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26(1):1-8.
20. Schieffer BM, Pham Q, Labus J, et al. Pain medication beliefs and medication misuse in chronic pain. J Pain. 2005;6(9):620-629.
21. Reid MC, Engles-Horton LL, Weber MB, Kerns RD, Rogers EL, O'Connor PG. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med. 2002;17(3):173-179.
22. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85-92.
23. Weisner CM, Campbell CI, Ray GT, et al. Trends in prescribed opi-oid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009;145(3):287-293. Epub2009Jul5.
24. Korff MV, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24(6):521-527.
25. Saunders K, Davis R, Stergachis A. Group health cooperative. In: Strom B, editor. Pharmacoepidemiology. 4th ed. New York: Wiley; 2005:221-239.
26. Selby J, Smith D, Johnson E, Raebel M, Friedman G, McFarland B. Kaiser Permanente Medical Care Program. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. New York: Wiley; 2005:241-259.
27. Agency Medical Director's Group (AMDG). Opioid dosing guideline for chronic non-cancer pain, opioid dose calculator. http://www.agencymeddirectors.wa.gov/opioiddosing.asp.
28. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1-3):163-173.
29. Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50(2):133-149.
30. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008;24(6):497-508.
31. Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097-1102.
32. Smith H, Passik S. Pain and Chemical Dependency. New York, NY: Oxford University Press; 2008.
33. Jackson S. Melancholia and Depression. New Haven, NY: Yale University Press; 1986.
34. Bodkin JA, Zornberg GL, Lukas SE, Cole JO. Buprenorphine treatment of refractory depression. J Clin Psychopharmacol. 1995;15(1):49-57.
35. Koran LM, Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M. Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2005;66(3):353-359.
36. Tenore PL. Psychotherapeutic benef ts of opioid agonist therapy. J Addict Dis. 2008;27(3):49-65.
37. Katon W, Sullivan M, Walker E. Medical symptoms without identi-f ed pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001; 134(9 Pt 2):917-925.
38. Breivik H. Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain. 2005;9(2):127-130.
39. Park J, Lavin R. Risk factors associated with opioid medication misuse in community-dwelling older adults with chronic pain. Clin J Pain. 2010;26(8):647-655.
40. Lin EHB, Tang L, Katon W, Hegel MT, Sullivan MD, Unützer J. Arthritis pain and disability: response to collaborative depression care. Gen Hosp Psychiatry. 2006;28(6):482-486.
41. Thielke SM, Fan MY, Sullivan M, Unützer J. Pain limits the effectiveness of collaborative care for depression. Am J Geriatr Psychiatry. 2007;15(8):699-707.